Genome and epigenomewide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease risk
R.F. Hillary, D.A. Gadd, D.L. McCartney, L. Shi, A. Campbell, R.M. Walker, C.W. Ritchie, I.J. Deary, K.L. Evans, A.J. NevadoHolgado, C. Hayward, D.J. Porteous, A.M. McIntosh, S. Lovestone, M.R. Robinson, R.E. Marioni, Alzheimer’s &; Dementia: Diagnosis, Assessment &; Disease Monitoring 14 (2022).